MSC Route of Delivery
Thursday, May 30, 2024 08:00 AM - 09:00 AM
Room 211
Science & Innovation
Concurrent Session
Chair:
Leading investigators in MSC therapeutics will explore the pros and cons of other routes of administration.
- Manoj Lalu, MD, PhD, FRCPC, The Ottawa Hospital, Canada
- Mark Lowdell, PhD, FRCPath, FRSB, University College London, United Kingdom, "Intra nasal administration of allogeneic human MSC in a preclinical model of intrapartum hypoxia – preparation for a clinical trial"
- Sara McCoy, MD, PhD, University of Wisconsin, United States, "Distal and Locoregional treatment: Cytokine-Stimulated MSCs for Gut and Glands"
- Sowmya Viswanathan, PhD, University Health Network, Canada, "Intra-articular administration of MSCs for knee Osteoarthritis"
Leading investigators in MSC therapeutics will explore the pros and cons of other routes of administration.
